Evaluation of Orthohepevirus C Infection as an Emerging Cause of Zoonotic Origin Disease

NCT05062967 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3257

Last updated 2021-09-30

No results posted yet for this study

Summary

The main objective of this study is to evaluate the prevalence and the clinical impact of Orthohepevirus C infection in different human populations, and to determine its zoonotic origin comparing the sequences obtained in both human and animal populations. This is an ambispective study where Orthohepevirus C infection will be evaluated in four high risk human population: i) patients with acute hepatitis, ii) patients with positive IgM antibody against Hepatitis E virus infection with undetectable viral load, iii) HIV infected individuals, and iv) solid organ transplant recipients. Furthermore, we will analyze three animal populations: i) suburban rodents, ii) domestic rodents, iii) wild carnivores. Viral sequences identified in both human and animal populations will be compared to evaluate the zoonotic origin of the infections.

Conditions

  • Hepatitis
  • Liver Diseases
  • Acute Hepatitis
  • Chronic Hepatitis
  • Liver Disease Chronic

Sponsors & Collaborators

  • Maimónides Biomedical Research Institute of Córdoba

    lead OTHER

Principal Investigators

  • ANTONIO RIVERO ROMÁN · Hospital Universitario Reina Sofía

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2024-10-01
Completion
2024-12-01

Countries

  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05062967 on ClinicalTrials.gov